InDex Pharmaceuticals Holding AB
STO:FLERIE
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Arista Networks Inc
NYSE:ANET
|
Communications
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
LU |
Spotify Technology SA
NYSE:SPOT
|
Media
|
|
US |
Boeing Co
NYSE:BA
|
Aerospace & Defense
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
CA |
Shopify Inc
NYSE:SHOP
|
Technology
|
|
PE |
Credicorp Ltd
NYSE:BAP
|
Banking
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Procter & Gamble Co
NYSE:PG
|
Consumer products
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
8.8
55.8
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Arista Networks Inc
NYSE:ANET
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Spotify Technology SA
NYSE:SPOT
|
LU | |
Boeing Co
NYSE:BA
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Shopify Inc
NYSE:SHOP
|
CA | |
Credicorp Ltd
NYSE:BAP
|
PE | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Procter & Gamble Co
NYSE:PG
|
US |
This alert will be permanently deleted.
InDex Pharmaceuticals Holding AB
PP&E Net
InDex Pharmaceuticals Holding AB
PP&E Net Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
I
|
InDex Pharmaceuticals Holding AB
STO:FLERIE
|
PP&E Net
kr1.1m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Calliditas Therapeutics AB
STO:CALTX
|
PP&E Net
kr59.4m
|
CAGR 3-Years
89%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
||
Camurus AB
STO:CAMX
|
PP&E Net
kr40.2m
|
CAGR 3-Years
6%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
||
S
|
Swedencare AB (publ)
STO:SECARE
|
PP&E Net
kr522.4m
|
CAGR 3-Years
118%
|
CAGR 5-Years
100%
|
CAGR 10-Years
N/A
|
|
IRLAB Therapeutics AB
STO:IRLAB A
|
PP&E Net
kr6.7m
|
CAGR 3-Years
16%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
||
Moberg Pharma AB (publ)
STO:MOB
|
PP&E Net
kr4.9m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
InDex Pharmaceuticals Holding AB
Glance View
InDex Pharmaceuticals Holding AB engages in the development of drugs for the treatment of diseases such as inflammation and cancer. The company is headquartered in Solna, Stockholm and currently employs 6 full-time employees. The company went IPO on 2016-10-11. The firm is focused in pharmaceuticals development. The firm's drug candidate is cobitolimod that helps in ulcerative colitis treatment. In addition, the Company develops a platform of patent protected substances, DNA based ImmunoModulatory Sequences (DIMS), that helps in the treatment of various immunological diseases. The firm also offers diagnostic kit DiBiCol, which is a PCR-based method that monitors seven biomarkers specific for ulcerative colitis or Crohn’s disease from a single colonic biopsy. InDex Pharmaceuticals Holding AB operates as a parent for InDex Pharmaceuticals AB and InDex Diagnostics AB. Among the Company's shareholders are SEB Venture Capital, Industrifonden and NeoMed Management.
See Also
What is InDex Pharmaceuticals Holding AB's PP&E Net?
PP&E Net
1.1m
SEK
Based on the financial report for Sep 30, 2024, InDex Pharmaceuticals Holding AB's PP&E Net amounts to 1.1m SEK.
What is InDex Pharmaceuticals Holding AB's PP&E Net growth rate?
PP&E Net CAGR 5Y
9%
Over the last year, the PP&E Net growth was -64%. The average annual PP&E Net growth rates for InDex Pharmaceuticals Holding AB have been -24% over the past three years , 9% over the past five years .